Lipolytic enzyme inhibitors
US5376640A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Nov 9, 1992 |
| Grant date | Dec 27, 1994 |
| Priority date | — |
| Expiry date | Nov 9, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23L33/17
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of inhibiting enzymatic hydrolysis of lipids in a mammal concerns orally administering an effective amount of a purothionin or an .epsilon.-polylysine of the formula: ##STR1## or a salt thereof, wherein n is a number of from 5 to 9, to a mammal in need thereof. Alternatively, the method concerns orally administering an .epsilon.-polylysine of the formula above or a salt thereof, wherein n is a number of from 4 to 30, to a mammal suffering from lipemia or obesity. The purothionin, .epsilon.-polylysine or salt thereof is a lipolytic enzyme inhibitor, useful as a dieting agent, an agent for the prevention of obesity and lipemia, and as an additive for food and feed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.